SARAH CARLISLE: Open Payments
NPI 1104062066 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$604 in 19 payments from 10 companies in 2025. Trend: 2023 $1,258 · 2024 $1,251 · 2025 $604
Food & beverage: $604
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $131 |
| Novo Nordisk Inc | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $84 |
| Lilly USA, LLC | 2 | $59 |
| Sumitomo Pharma America, Inc. | 2 | $50 |
| PFIZER INC. | 2 | $50 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: JARDIANCE, Ozempic, BREZTRI, GEMTESA, PREVNAR 20, SHINGRIX, Kerendia, VOQUEZNA.
Industry payments across MI — which companies pay providers there.
